Notice: Prescription Drug List (PDL): Triamcinolone acetonide (English, HTML)
View metadata and access the original English HTML file: Notice: Prescription Drug List (PDL): Triamcinolone acetonide.
- Format
- HTML
- Access
- file-only
- Publisher-reported update
- 2023-09-30
The purpose of this Notice of Intent to Amend is to notify that, as a result of consultation, Health Canada will revise the listing for Adrenocortical hormones on the Prescription Drug List (PDL) to exempt Triamcinolone acetonide.
Data overview
- Formats
- HTML
- File languages
- English
- Available actions
- Access original file